Sympathetic ophthalmia.
A 29-year-old woman developed severe ocular manifestations of sympathetic ophthalmia on the day after enucleation of a blind, painful eye, and four weeks after a penetrating ocular injury. She was observed for one year with fundus photography, fluorescein angiography, and electrophysiologic tests. Nystagmus, a rare systemic manifestation of sympathetic ophthalmia, was noted early in the course of her disease and was accompanied by vertigo, truncal ataxia, and cerebrospinal fluid pleocytosis. Enucleation and intensive corticosteroid treatment resolved the process; however, she has experienced recurrences in the two-year follow-up period.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001259:Ataxia / Q000150:complications; D002555:Cerebrospinal Fluid / Q000166:cytology; D005123:Eye / Q000473:pathology; D005131:Eye Injuries / Q000150:complications*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D009759:Nystagmus, Pathologic / Q000150:complications; D009879:Ophthalmia, Sympathetic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012163:Retinal Detachment / Q000150:complications*; D014717:Vertigo / Q000150:complications
D000305:Adrenal Cortex Hormones